profiles and sites of analgesic action of the drug in animals have not yet been shown. Satoh et al. (3) have demonstrated that the flexor reflex induced by intra-arterial injection of bradykinin in the rat was an objective and sensitive index for evaluating various analgesic drugs. Pentazocine and cyclazocine were shown to produce analgesic effects in the bradykinin-induced flexor reflex test (4) , though the drugs did not elicit anti nociceptive effects without marked im pairment in the tail-pinch, tail-flick and hot plate methods. In the present experiments, anti nociceptive effects of ciramadol were evaluated using three analgesic tests: the tail-pinch, hot-plate and bradykinin-induced flexor reflex tests. Further, in order to search for the sites of analgesic action of ciramadol in rats, the drug was not only administered systemically, but also applied locally to the lumbar subarachnoid space and nuclei re ticularis paragigantocellularis and giganto cellularis (NRPG-NRGC), which are sensi tive sites to morphine in the production of analgesia (5, 6). The tail-pinch tests were performed in male dd-K mice (14-17 g) and Sprague Dawley rats g) according to the method described by Takagi et al. The hot-plate tests were done using male dd-K mice (22-26 g). The latencies of paw licking reactions of mice placed on a hot plate at 55+0.1 °C were determined. Each mouse was tested only once at 30 min after subcutaneous administration of cir amadol or physiological saline.
The bradykinin-induced flexor reflex test was carried out on conscious male Sprague Dawley rats (160-260 g) according to the methods described by Satoh et al. (3) . Bradykinin (2-4 i g in 0.2 ml physiological saline) was injected into the right common iliac artery at intervals of 10 or 20 min through a cannula implanted retrogradely into the left common iliac artery from the left femoral artery. Bradykinin-induced flexor reflexes of the right hind limb were recorded on a kymograph. When, after administration of ciramadol, the magnitude of the reflexes was less than 25% of the smallest value among control trials, the effect was regarded as analgesic.
The ED50 values and 95% confidence limits were determined according to the method of Litchfield and Wilcoxon (9).
For injection of ciramadol into the lumbar subarachnoid space (intrathecal injection), a polyethylene tube (13 cm length and 0.5 mm o.d.) was inserted through a puncture in the atlanto-occipital membrane so that the tip rested on the dorsal aspect of the rostra) margin of the lumbar enlargement and fixed to the skull with dental cement. Such an operation was done under ether anesthesia immediately before cannulation for bradykinin injection. Ciramadol was dissolved in physio logical saline and injected intrathecally in a volume of 10 icl.
Micro injection
of ciramadol into the NRPG-NRGC was done according to the method described by Akaike et al. (8). Ciramadol dissolved in physiological saline at various concentrations was injected into the NRPG-NRGC in a volume of 0.5 ,ul from an injection cannula introduced through a guide cannula which had been unilaterally implanted under pentobarbital anesthesia one week before experiments so that the tip of the guide cannula was located 4 mm above the NRPG-NRGC.
At the end of each experiment, the microinjection site was histologically verified to be in the NRPG N RGC. Each rat was given only one dose of ciramadol, subcutaneously, intrathecally or into the NRPG-NRGC.
Subcutaneous administration of ciradadol did not produce any detectable effect with the tail-pinch tests in mice at doses of 5, 10, 20, 50 and 100 mg/kg (10 mice per each dose) and in rats at doses of 5 and 50 mg/kg (3 and 4 rats, respectively).
Furthermore, ciramadol in subcutaneous doses of 5, 10 and 50 mg/kg did not significantly influence latencies of paw-licking and jumping reactions (10 mice per each dose) in the hot-plate test.
On the other hand, the bradykinin-induced flexor reflexes of rats were suppressed by subcutaneous ciramadol in a dose-dependent manner at doses of 0.5, 1, 2 and 4 mg/kg.
Such an analgesic effect appeared within 15 min after administration of the drug and lasted for 70 min or more. The ED50 value (95% confidence limits) was 1.18 (0.63-2.23) mg/kg. The suppressive effect of ciramadol was antagonized by naloxone (0.1 mg/kg, i.v.) given 30 min after ciramadol adminis tration (Fig. 1) .
Intrathecal injection of ciramadol in doses of 0.1, 0.5 and 1 ng/rat produced a dose dependent analgesic effect in the bradykinin induced flexor reflex test. The ED50 value was 0.32 (0.15-0.63)
,erg/rat. Such an effect appeared within 5 min after the injection and lasted for 60 min or more in 5 out of 10 rats in which the analgesic effects were produced by intrathecal ciramadol. Ciramadol micro injected into the NRPG-NRGC produced a dose-dependent suppression of bradykinin induced flexor reflexes in doses of 1, 2 and 5 ,ag/rat. The ED50 value was 1.5 (0.84-2.7) /tg/rat.
The suppressive effects appeared within 5 min after the microinjections and recovered within 60 min in 7 out of 10 rats in which the effects were produced by micro injections of the drug into the NRPG-NRGC. Longer lasting analgesic effects observed in four rats injected intrathecally and in three rats microinjected into the NRPG-NRGC were reversed by naloxone (0.1 mg/kg, i.v.)
given 80 or 100 min after ciramadol ap plications (Fig. 2) .
Ciramadol did not elicit any motor impair ment at the doses used in the bradykinin induced flexor reflex tests, suggesting that the suppressive effects of ciramadol on the bradykinin-induced flexor reflexes were hardly due to inhibitory effects of the drug on Such results fairly correspond to clinical data that the analgesic potency of ciramadol to post operative pain was nearly equal to that of pentazocine (2) . Micro-applications of ciramadol to the lumbar subarachnoid space and NRPG N RGC produced dose-dependent analgesic effects in the bradykinin-induced flexor reflex test. The potency in the former case was 4.7 times more than that in the latter case, suggesting that the action of ciramadol on the spinal cord more greatly contributes to the production of analgesia by the drug than that on the supraspinal structures like NRPG NRGC. On the other hand, in the tail-pinch test, the analgesic potency of morphine applied to the lumbar subarachnoid space has been shown to be 13 times less than that of the drug microinjected into the NRPG NRGC (6). Moreover, the analgesic effect of pentazocine in the bradykinin-induced flexor reflex test was much less in spinal rats than in intact rats (4). These observations suggest the main site of analgesic action of ciramadol is different from that of morphine and pentazocine; the former is at the spinal level, but the latter is in the supraspinal structures such as the N RPG-N RGC. 
